PT Kalbe Farma Tbk., together with its subsidiaries, engages in the development, manufacture, and trading of pharmaceutical products in Indonesia. It operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business, and E-health products. In addition, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. The company was incorporated in 1966 and is headquartered in Jakarta, Indonesia.
Frequently asked questions
What sector does Kalbe Farma Tbk PT (KLBF) operate in?
Kalbe Farma Tbk PT belongs to the Healthcare sector and operates in the Drug Manufacturers - General industry.
What is Kalbe Farma Tbk PT (KLBF) current stock price?
As of the latest data, Kalbe Farma Tbk PT stock price is IDR 760, with a previous close of IDR 760.
What is Kalbe Farma Tbk PT (KLBF) current market capitalization?
Kalbe Farma Tbk PT market cap is approximately 34.39 trillion.
What is Kalbe Farma Tbk PT (KLBF) Earnings Per Share (EPS)?
The trailing EPS is IDR 80, and the forward EPS is IDR 87.
What is Kalbe Farma Tbk PT (KLBF) Price-to-Earnings (P/E) ratio?
Kalbe Farma Tbk PT current P/E ratio is 9.55, with a forward P/E of 8.75.
What is Kalbe Farma Tbk PT (KLBF) EBITDA?
Kalbe Farma Tbk PT EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 1.36 trillion.
Does Kalbe Farma Tbk PT (KLBF) pay dividends?
Yes. Kalbe Farma Tbk PT pays annual dividends with an annualized yield of 2.63% and an estimated annual payout of IDR 20 per share.
When is the next ex-dividend date for Kalbe Farma Tbk PT (KLBF)?
The next ex-dividend date is scheduled for June 04, 2027.
What is Kalbe Farma Tbk PT (KLBF) beta (volatility) score?
Kalbe Farma Tbk PT has a beta of -0.085, indicating lower volatility than the overall market.
